TrialJournal of women's health (2002)2023

Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306.

Oluwatosin Goje et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.